Flagship Ventures Fund V General Partner LLC 4
4 · Sana Biotechnology, Inc. · Filed Feb 10, 2021
Insider Transaction Report
Form 4
Transactions
- Conversion
Series A-2 Convertible Preferred Stock
2021-02-08−1,487,371→ 0 total(indirect: See footnotes)→ Common Stock (1,487,371 underlying) - Conversion
Series A-2 Convertible Preferred Stock
2021-02-08−11,441,326→ 0 total(indirect: See footnotes)→ Common Stock (11,441,326 underlying) - Conversion
Series A-2 Convertible Preferred Stock
2021-02-08−11,585,199→ 0 total(indirect: See footnotes)→ Common Stock (11,585,199 underlying) - Conversion
Series A-2 Convertible Preferred Stock
2021-02-08−9,725,122→ 0 total(indirect: See footnotes)→ Common Stock (9,725,122 underlying) - Conversion
Common Stock
2021-02-08+1,487,371→ 1,487,371 total(indirect: See footnotes) - Conversion
Common Stock
2021-02-08+9,725,122→ 9,725,122 total(indirect: See footnotes) - Conversion
Common Stock
2021-02-08+11,441,326→ 11,441,326 total(indirect: See footnotes) - Conversion
Common Stock
2021-02-08+11,585,199→ 11,585,199 total(indirect: See footnotes)
Footnotes (8)
- [F1]The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering.
- [F2]Represents shares held directly by Flagship V VentureLabs Rx Fund, L.P. ("Flagship Fund V Rx").
- [F3]Represents shares held directly by Flagship Pioneering Fund VI, L.P. ("Flagship Pioneering VI").
- [F4]Represents shares held directly by Flagship VentureLabs V LLC. ("VentureLabs V").
- [F5]Represents shares held directly by Flagship Ventures Fund V, L.P. ("Flagship Fund V" and together with Flagship Fund V Rx, Flagship Pioneering VI, and VentureLabs V, the "Flagship Pioneering Funds").
- [F6]VentureLabs V Manager LLC ("VentureLabs V Manager") is the manager of VentureLabs V. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of VentureLabs V Manager. The General Partner of Flagship Pioneering VI is Flagship Pioneering Fund VI General Partner LLC ("Flagship Pioneering VI GP"). The manager of Flagship Pioneering VI GP is Flagship Pioneering. The General Partner of Flagship Fund V and Flagship Fund V Rx is Flagship Ventures Fund V General Partner LLC ("Flagship V GP" and, together with VentureLabs V Manager, Flagship Pioneering, and Flagship Pioneering VI GP, the "Flagship General Partners").
- [F7](continued from footnote 6) Noubar B. Afeyan, Ph.D. is the sole Director of Flagship Pioneering and may be deemed to have sole voting and investment control over all the shares held by VentureLabs V and Flagship Fund VI. In addition, Noubar B. Afeyan, Ph.D. serves as the sole manager of Flagship V GP and may be deemed to possess sole voting and investment control over all the shares held by Flagship Fund V and Flagship Fund V Rx. None of the Flagship General Partners nor Noubar B. Afeyan, Ph.D. directly own any of the shares held by the Flagship Pioneering Funds, and each of the Flagship General Partners and Noubar Afeyan, Ph.D. disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.
- [F8]The expiration date is not relevant to the conversion of these securities.